fbpx

Bezos Invests in Nvidia Rival

وَلَا تَبْخَسُوا۟ ٱلنَّاسَ أَشْيَآءَهُمْ وَلَا تَعْثَوْا۟ فِى ٱلْأَرْضِ مُفْسِدِينَ

And do not defraud people of their property. Nor go about spreading corruption in the land. (Qur’an, 26:183)

Market Snapshot

▲  S&P 500 +1.49%

▲ SPUS +1.27%

▼  MSCI World Islamic -0.10%

*Market data for last week ending Friday


Last Week’s Review

Dell Technologies Earnings Highlight Sector-Wide Challenges: Dell’s earnings on November 26 came in slightly below expectations, with revenue at ~$24.4 billion. The results reflect broader struggles in the tech hardware industry, especially in the consumer segment, which continues to face weak demand. While Dell’s cost efficiency provided some stability, overall pressure on the tech sector suggests limited growth opportunities in the near term.

PCE Price Index Shows Softer Inflation: The PCE Price Index, released on November 27, rose by 2.1% year-over-year, slightly below the expected 2.3%. This lower-than-expected inflation eased concerns and raised hopes that the Federal Reserve may avoid further interest rate hikes. Investors responded positively, especially in tech and growth sectors.


This Week’s Outlook

Unemployment Rate and Nonfarm Payrolls (December 6): The upcoming unemployment report is expected to show a stable labor market. A steady outcome would support current Federal Reserve policies, while any surprises could shift rate expectations.

Retail Earnings Highlight Consumer Spending Trends (December 5): Earnings from Dollar General, Ulta Beauty, and Lululemon Athletica will provide insights into consumer spending across different price points, ranging from value-focused to premium retail. Analysts expect mixed results, reflecting shifts in consumer behavior and economic pressures.


Curated Reads

Bezos Invests in Nvidia Rival
Jeff Bezos has made a substantial investment in Tenstorrent, a chipmaker aiming to challenge Nvidia’s dominance in the AI hardware sector. This move signals increased competition in the AI market, with Tenstorrent focusing on creating innovative and cost-effective AI solutions. Investors are watching closely as Bezos’s backing brings added credibility to the company. [Read]

Intel CEO Steps Down Amid Competitive Struggles
Intel’s CEO Pat Gelsinger has stepped down, raising questions about the company’s future direction as it faces stiff competition in the semiconductor industry. Analysts predict that Intel’s new leadership will need to aggressively pivot towards AI and advanced chip manufacturing to regain market share and restore investor confidence. The market’s response has been cautious, with investors waiting to see whether Intel can execute a successful turnaround strategy under new leadership. [Read]


Chart of the Week

Regeneron Pharmaceuticals (NASDAQ: REGN) is uniquely positioned to navigate a challenging environment for the pharmaceutical sector while capitalizing on its strengths. With oncology funding remaining a bipartisan priority, Regeneron’s world-class cancer treatment portfolio ensures it is well-placed to gain a larger share of this critical market.

Financially, Regeneron sets itself apart with a cash position sufficient to pay off all outstanding debt—a rare achievement in the sector. This provides unmatched flexibility, allowing the company to withstand market volatility or invest aggressively in growth opportunities. In addition, its consistently high profit margins serve as a buffer against pricing pressures that often disrupt the pharmaceutical industry.

Market sentiment reflects this strength. The most bearish analyst target for Regeneron still suggests a 17% upside, signaling broad confidence in its growth trajectory. Combining strategic focus, financial discipline, and operational resilience, Regeneron is exceptionally well-positioned to deliver sustained value in the evolving healthcare landscape.

Current Price: $751
Target Price: $850

Disclaimer: This information is accurate as of the date of publishing and is not intended as investment advice.


Your Questions

What are some good ETFs to get started with in Halal investing?

SPUS is a good starting point. You can use our Portfolio Builder to see a list of ETFs and get portfolio suggestions based on your risk profile. (Answered by Faraz Omar, AAOIFI Certified Shariah Advisor and Auditor)

You may ask your questions in our Community or email them to support@muslimxchange.com

Share this post
Picture of Ayaan Khan
Ayaan Khan
Intern at MuslimXchange and Computer Science student. Focused on broadening financial literacy and promoting educated investing within the Muslim community, while demonstrating that market outperformance is possible through Shariah-compliant principles. Aspiring to enter investment management, with a track record of beating the market by 5.3% over only three months.
Related Posts

Responses